The Pharma Data

MAY 13, 2021

Testimonials are not necessarily representative of all of those who will use our products. Some of our testimonials are provided by customers who have received promotional offers in exchange for their participation. The testimonials displayed are given verbatim except for correction of grammatical or typing errors. Pediatr Ann.

Disease 52

Disease Production Testimonials Science 52

Drug & Device Law

JULY 24, 2023

2019) (“ PATDC82 I ”), because the third-party payor (“TPP”) plaintiffs were allowed to misuse RICO to pursue what was essentially a garden variety inadequate warning case – that the drug Actos increased the risk of bladder cancer. 341 (2001). Takeda Pharmaceuticals Co. , 3d 1243 (9th Cir. Indeed, that’s what the label says.

Testimonials 52

Testimonials Pharmacy FDA Doctors 52

Drug & Device Law

DECEMBER 27, 2022

Many of the tests were on pills that the laboratory itself “manufactured” from bulk raw ranitidine although “consumers do not ingest ranitidine API [active product ingredient] not manufactured into a finished drug product.” Reliance on studies involving other drugs, while ignoring ranitidine-related epidemiology. at *117-18.

Laboratories 59

Laboratories FDA Production International 59

Drug & Device Law

AUGUST 26, 2022

After more than a month away at trial, we probably should not have picked a case that hit so close to home, so to speak. 1996), which rejected strict liability in a prescription drug case, to cases over prescription medical devices. 2014), a prescription drug case. Atrium Medical Corp. , — F. 3d –, 2022 WL 3357485 (E.D.

Production 59

Production Testimonials Marketing Trials 59

Drug & Device Law

NOVEMBER 28, 2022

Three years ago we published a lengthy post, “ Stupid Expert Tricks ,” detailing several of the other side’s egregious attempts at passing off junk science “experts” as the real thing, along with our side’s trials and tribulations during the course of unmasking these phonies. 2001) (Kilburn); and Wade-Greaux v. 3d 179, 181-87 (D.

Testimonials 59

Testimonials Regulations Research International 59

Drug & Device Law

FEBRUARY 20, 2023

Drug manufacturers often could trade a little less efficacy for a little more safety, but the safest design is not always the best one. to determine whether a proposed alternative drug would have received FDA approval.” For physicians to prescribe such a safer drug, it must reach the market. Wyeth LLC , 562 U.S. 2d 506 (N.Y.

FDA 59

FDA FDA Approval Testimonials Vaccine 59

Drug & Device Law

JUNE 6, 2022

Thus a confident learned intermediary’s testimony will defeat causation as a matter of law by stating that, notwithstanding a poor result, the treatment provided was standard of care, and even in hindsight they would not do anything different. Confident learned intermediaries stand by their medical decisions. Medrano , 28 S.W.3d

Testimonials 59

Testimonials Production Pharmaceuticals Treatment 59